| |
|
|
|
Harvard Bioscience Inc.  
|
|
4.64 -0.07 (-0.01%) |
10-17 16:00 |
|
Open: |
4.7 |
Pre close: |
4.71 |
Target:
|
6.07 
|
|
High: |
4.75 |
Low: |
4.55 |
Resistance:
|
5.20
5.75
|
|
Volume: |
70,186 |
Market Cap: |
170M |
Support:
|
4.31
3.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.61
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
4.87 |
Signal(12,26,9): |
-0.25 |
|
MA(100): |
5.34 |
Stochastic Oscillator |
%K(14,3):
|
33.67 |
|
MA(250): |
4.71 |
%D(3): |
30.75 |
|
Average Volume(K) |
3-Month: |
23931
|
52-Week |
High:
|
6.70 |
|
10-Days: |
11401 |
Low: |
2.95 |
|
RSI |
RSI(14):
|
37.10 |
Change(%): |
22.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.110 |
Return on Equity (ttm) |
-6.4 |
Shares Out. (M) |
36.58 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-3.6 |
Shares Float (M) |
28.95 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
2.15 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
66.3 |
% Held by Institutions |
72.80 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
0.318 |
Shares Short (K) |
1416 |
|
Book Value (p.s.) |
2.150 |
EBITDA (p.s.) |
0.023 |
P/E |
42.18 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.16 |
|
Profit Margin |
-5.41 |
Operating Cash Flow
(M) |
2.92 |
P/S |
48633584.00 |
|
Operating Margin |
2.09 |
Levered Free Cash Flow
(M) |
11.45 |
P/CF |
58.13 |
|
|
|
|
|
|
